Technology collaboration – TOKR20150514002 OFFER
A university from South Korea has developed a therapeutic method for treatment of allergies and inflammatory conditions. The outcome of the technology is to inhibit a factor that causes allergic inflammation. The technology can be expected to be used for first-in-class drugs in relevant areas, e.g., pharmaceuticals, medicines, drugs, etc. The university is looking for partners who are interested in joint R&D with the object of commercialization of the technology.
Powered by WPeMatico